TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
-2.75%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.85B
AUM Growth
-$260M
(-8.4%)
Cap. Flow
-$73M
Cap. Flow
% of AUM
-2.56%
Top 10 Holdings %
Top 10 Hldgs %
35.96%
Holding
185
New
14
Increased
26
Reduced
26
Closed
10
Top Buys
| 1 |
AstraZeneca
AZN
|
$13.5M |
| 2 |
Stryker
SYK
|
$11.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$9.35M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$8.6M |
| 5 |
Becton Dickinson
BDX
|
$8.15M |
Top Sells
| 1 |
Moderna
MRNA
|
$37.6M |
| 2 |
Thermo Fisher Scientific
TMO
|
$32.3M |
| 3 |
Merck
MRK
|
$17.4M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$16.4M |
| 5 |
Danaher
DHR
|
$15.3M |
Sector Composition
| 1 | Healthcare | 95.64% |
| 2 | Real Estate | 3.21% |
| 3 | Industrials | 0.19% |
